Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

V. Madhavan, Mahesh; Bikdeli, Behnood; Gupta, Aakriti; Jiménez, David; Burton, John; Der‐Nigoghossian, Caroline; Chuich, Taylor; Nabavi Nouri, Shayan; Dreyfus, Isaac; Driggin, Elissa; S. Sethi, Sanjum; Sehgal, Kartik; Chatterjee, Saurav; Ageno, Walter; Madjid, Mohammad; Guo, Yutao; Tang, Liang; Hu, Yu; Bertoletti, Laurent; Giri, Jay; Cushman, Mary; Quéré, I.; Dimakakos, Evangelos; Michael Gibson, C.; Lippi, Giuseppe; J. Favaloro, Emmanuel; Fareed, Jawed; Tafur, Alfonso; P. Francese, Dominic; Batra, Jaya; Falanga, Anna; J. Clerkin, Kevin; Uriel, Nir; J. Kirtane, Ajay; McLintock, Claire; J. Hunt, Beverley; C. Spyropoulos, Alex; D. Barnes, Geoffrey; W. Eikelboom, John; Weinberg, Ido; Schulman, Sam; Carrier, Marc; Piazza, Gregory; A. Beckman, Joshua; B. Leon, Martin; W. Stone, Gregg; Rosenkranz, Stephan; Z. Goldhaber, Samuel; A. Parikh, Sahil; Monréal, Manuel; M. Krumholz, Harlan; Konstantinides, Stavros; I. Weitz, Jeffrey; Y.H. Lip, Gregory; Global COVID-19 Thrombosis Collaborative Group, The

doi:10.1055/s-0040-1713152

Public

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

Published in Thrombosis and Haemostasis • May 30, 2020

Authors:

Mahesh V. Madhavan

Behnood Bikdeli

Aakriti Gupta

Abstract

Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected contribution of thrombotic events to morbidity and mortality in COVID-19 patients has prompted a search for novel potentia...

Subject

Coronavirus disease 2019 (COVID-19)

2019-20 coronavirus outbreak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!